2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| El Coronado Holdings, LLC | — | 3,832,081 | Dec 5, 2012 |
| Vivo Ventures VII, Llc | 10% Owner | 3,163,105 | Nov 9, 2015 |
| Vivo Ventures Fund VII, L.P. | 10% Owner | 3,098,503 | Oct 29, 2013 |
| Vivo Ventures VII Affiliates Fund, L.P. | 10% Owner | 3,098,503 | Oct 29, 2013 |
| Akkaraju Srinivas | 10% Owner | 2,502,775 | Feb 20, 2013 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | May 21, 2024 | Wood Steven D | Director | Neutral | 82.5 | +3,100 | 4.49% | ✗ | - |
| May 16, 2024 | May 20, 2024 | Flynn James P | Director | Neutral | 90.0 | +7,900 | 100.00% | ✗ | - |
| Dec 18, 2023 | Jan 12, 2024 | Flynn James P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 18, 2023 | Jan 12, 2024 | Wood Steven D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 18, 2023 | Dec 20, 2023 | Wood Steven D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 18, 2023 | Dec 20, 2023 | Flynn James P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 14, 2023 | Wood Steven D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 6, 2023 | Datoo Taheer | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 3, 2023 | Flynn James P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 20, 2023 | Oct 24, 2023 | Funicular Funds, LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 20, 2023 | Oct 24, 2023 | Anson Funds Management LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2023 | Oct 13, 2023 | Funicular Funds, LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2023 | Oct 13, 2023 | Anson Funds Management LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2023 | Oct 12, 2023 | Baltic Charles V. III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2023 | Oct 12, 2023 | DRISCOLL FREDERICK W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2023 | Oct 12, 2023 | Glover Nicholas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2023 | Oct 12, 2023 | GOLD DANIEL P PHD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2023 | Oct 12, 2023 | HOWSON TAMAR D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2023 | Oct 12, 2023 | Reynolds Thomas C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2023 | Oct 12, 2023 | KANGO SUJAY | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 29, 2023 | Oct 12, 2023 | GHALIE RICHARD G | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 22, 2023 | Sep 25, 2023 | Anson Funds Management LP | 10% Owner | Buy | 92.5 | +48,060 | 5.89% | ✗ | $329.3K |
| Sep 22, 2023 | Sep 25, 2023 | Funicular Funds, LP | 10% Owner | Buy | 90.0 | +32,040 | 7.47% | ✗ | $219.6K |
| Sep 20, 2023 | Sep 22, 2023 | Anson Funds Management LP | 10% Owner | Buy | 97.5 | +153,600 | 23.18% | ✗ | $938.2K |
| Sep 20, 2023 | Sep 22, 2023 | Funicular Funds, LP | 10% Owner | Buy | 97.5 | +102,400 | 31.37% | ✗ | $625.5K |
| Aug 1, 2023 | File Justin J. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 2, 2023 | Jun 6, 2023 | Urso David M | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 30, 2023 | Anson Funds Management LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 30, 2023 | Funicular Funds, LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 28, 2023 | Mar 1, 2023 | Baltic Charles V. III | Director | Buy | 91.3 | +81,500 | 275.34% | ✗ | $18.3K |
| Jul 5, 2022 | Jul 7, 2022 | Baltic Charles V. III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | DRISCOLL FREDERICK W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | Glover Nicholas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | HOWSON TAMAR D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | Cohen Cheryl | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | GOLD DANIEL P PHD | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | Drazba Brian G. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | Reynolds Thomas C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | White Christine Anna | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | Urso David M | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | KANGO SUJAY | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 5, 2022 | Jul 7, 2022 | GHALIE RICHARD G | Chief Medical Officer | Sell | 47.5 | -8,196 | -22.08% | ✗ | $4.4K |
| Nov 22, 2021 | Nov 23, 2021 | KANGO SUJAY | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 23, 2021 | KANGO SUJAY | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 1, 2021 | Jul 6, 2021 | White Christine Anna | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Reynolds Thomas C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | HOWSON TAMAR D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Glover Nicholas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | DRISCOLL FREDERICK W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Cohen Cheryl | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Clemens Kevan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Baltic Charles V. III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | GHALIE RICHARD G | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Drazba Brian G. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2021 | Jul 6, 2021 | Urso David M | COO | Sell | 42.5 | -24,825 | -33.50% | ✗ | $73K |
| Jul 2, 2021 | Jul 6, 2021 | GOLD DANIEL P PHD | CEO | Sell | 42.5 | -41,320 | -9.01% | ✗ | $121.5K |
| May 25, 2021 | May 27, 2021 | GOLD DANIEL P PHD | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 3, 2021 | May 5, 2021 | GHALIE RICHARD G | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 5, 2021 | GHALIE RICHARD G | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 23, 2021 | Feb 24, 2021 | DRISCOLL FREDERICK W | Director | Sell | 22.5 | -25,000 | -40.00% | ✗ | $100.6K |
| Jul 23, 2020 | Jul 27, 2020 | GOLD DANIEL P PHD | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | White Christine Anna | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | Glover Nicholas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | Reynolds Thomas C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | DRISCOLL FREDERICK W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | Urso David M | COO | Neutral | 90.0 | +50,000 | 207.42% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | Mass Robert D. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | HOWSON TAMAR D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | Drazba Brian G. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | Clemens Kevan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | Baltic Charles V. III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | GOLD DANIEL P PHD | CEO | Neutral | 90.0 | +80,000 | 22.12% | ✗ | - |
| Jul 2, 2020 | Jul 7, 2020 | Cohen Cheryl | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 10, 2020 | Apr 14, 2020 | Cohen Cheryl | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 14, 2020 | Cohen Cheryl | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 19, 2019 | Dec 20, 2019 | Reynolds Thomas C | Director | Buy | 91.3 | +10,000 | 100.00% | ✗ | $16K |
| Dec 19, 2019 | Dec 20, 2019 | DRISCOLL FREDERICK W | Director | Buy | 95.0 | +62,500 | 100.00% | ✗ | $100K |
| Dec 19, 2019 | Dec 20, 2019 | Drazba Brian G. | CFO | Buy | 91.3 | +12,500 | 50.00% | ✗ | $20K |
| Dec 19, 2019 | Dec 20, 2019 | GOLD DANIEL P PHD | CEO | Buy | 86.3 | +18,750 | 5.47% | ✗ | $30K |
| Sep 27, 2019 | Oct 1, 2019 | GOLD DANIEL P PHD | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 6, 2019 | Sep 9, 2019 | White Christine Anna | Director | Buy | 91.3 | +15,000 | 100.00% | ✗ | $26.1K |
| Jul 1, 2019 | Jul 3, 2019 | Urso David M | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | Mass Robert D. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | GOLD DANIEL P PHD | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | Drazba Brian G. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | White Christine Anna | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | Rueckert William Dodge | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | Reynolds Thomas C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | Glover Nicholas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | DRISCOLL FREDERICK W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | Clemens Kevan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | Baltic Charles V. III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2019 | Jul 3, 2019 | HOWSON TAMAR D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 3, 2019 | HOWSON TAMAR D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 6, 2018 | Sep 6, 2018 | GOLD DANIEL P PHD | CEO | Sell | 42.5 | -50,938 | -13.63% | ✗ | $191K |
| Aug 6, 2018 | Aug 8, 2018 | Urso David M | COO | Sell | 42.5 | -27,264 | -53.07% | ✗ | $100.7K |
| Aug 6, 2018 | Aug 8, 2018 | Mass Robert D. | Chief Medical Officer | Sell | 42.5 | -17,709 | -34.47% | ✗ | $66.4K |
| Aug 6, 2018 | Aug 8, 2018 | GOLD DANIEL P PHD | CEO | Sell | 42.5 | -54,093 | -14.47% | ✗ | $202.8K |
| Jul 12, 2018 | Jul 16, 2018 | Urso David M | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 12, 2018 | Jul 16, 2018 | Mass Robert D. | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |